At the Annual General Meeting in Recipharm AB (publ) on May 13, 2019, the shareholders adopted the resolutions summarized below:
· The presented annual report was adopted and the Board of Directors and the CEO were discharged for liability in respect of the financial year 2018.
· The proposed dividend of SEK 1.25 per share was approved and that the record day should be Wednesday, May 15, 2019.
· The proposed fees to the Board of Directors, its committees and the auditor were approved.
· Marianne Dicander Alexandersson, Lars Backsell, Carlos von Bonhorst, Anders G. Carlberg,